Hyperplasia of dermal microvascular pericytes in scleroderma

Journal of Cutaneous Pathology

Volumn 31, Issue 6, 2004, Pages 431-440

  Helmbold, Peter ^a,b   Fiedler, Eckhard ^a   Fischer, Matthias ^a   Marsch, Wolfgang Ch ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

ADULT; ARTICLE; CAPILLARY DENSITY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MICROANGIOPATHY; MICROVASCULATURE; PERICYTE; SCLERODERMA; SKIN BIOPSY; SKIN BLOOD VESSEL; VENULE;

ADOLESCENT; ADULT; AGED; CAPILLARIES; CELL COUNT; COLLAGEN TYPE IV; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PERICYTES; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SKIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 3042589910     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00203.x     Document Type: Article

References (36)

1. Sapadin AN, Esser AC, Fleischmajer R. Immunopathogenesis of scleroderma - evolving concepts. Mt Sinai J Med 2001; 68: 233.
2. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428.
3. Stüttgen G. Die terminalen Blutgefäße der Haut bei Kollagenosen und generalisierten Vaskulitiden. Med Welt 1975; 23: 1126.
4. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by "wide-field" microscopy. Arthritis Rheum 1973; 16: 619.
5. Fleischmajer R, Perlish JS. Capillary alterations in scleroderma. J Am Acad Dermatol 1980; 2: 161.
6. Fleischmajer R, Perlish JS, Reeves JR. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977; 20: 975.
7. Scharffetter K, Lankat-Buttgereit B, Krieg T. Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest 1988; 18: 9.
8. Yamamoto T, Eckes B, Krieg T. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun 2001; 281: 200.
9. Sato Y, Rifkin DB. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 1989; 109: 309.
10. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 1989; 86: 4544.
11. Katenkamp D, Stiller D. Die Dupuytren Kontraktur - Resultat einer Gefäßhyperproliferation? Zentralbl Allg Pathol 1976; 120: 91.
12. King GL. Cell biology as an approach to the study of the vascular complications of diabetes. Metabolism 1985; 34: 17.
13. Herman IM, Jacobson S. In situ analysis of microvascular pericytes in hypertensive rat brains. Tissue Cell 1988; 20: 1.
14. Laaff H, Vandscheidt W, Weiss JM, Schaefer HE, Schoepf E. Immunohistochemical investigation of pericytes in chronic venous insufficiency. Vasa 1991; 20: 323.
15. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125: 1591.
16. Canfield AE, Doherty MJ, Wood AC, et al. Role of pericytes in vascular calcification: a review. Z Kardiol 2000; 89 (Suppl. 2): 20.
17. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 2000; 60: 1388.
18. Suh DY. Understanding angiogenesis and its clinical applications. Ann Clin Lab Sci 2000; 30: 227.
19. Helmbold P, Wohlrab J, Marsch WC, Nayak RC. Human dermal pericytes express 3G5 ganglioside - a new approach for microvessel histology in the skin. J Cutan Pathol 2001; 28: 206.
20. Helmbold P, Nayak RC, Marsch WC, Herman IM. Isolation and in vitro characterization of human dermal microvascular pericytes. Microvasc Res 2001; 61: 160.
21. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 1993; 55: 739.
22. Braverman IM. Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. J Invest Dermatol 1989; 93: 2S.
23. Nayak RC, Berman AB, George KL, Eisenbarth GS, King GL. A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J Exp Med 1988; 167: 1003.
24. Kissin EY, Korn JH. Fibrosis in scleroderma. Rheum Dis Clin North Am 2003; 29: 351.
25. Nehls V, Denzer K, Drenckhahn D. Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 1992; 270: 469.
26. D'Amore PA, Sweet E. Effects of hyperoxia on microvascular cells in vitro. In Vitro Cell Dev Biol 1987; 23: 123.
27. Addison DJ, Garner A, Ashton N. Degeneration of intramural pericytes in diabetic retinopathy. Br Med J 1970; 1: 264.
28. Stitt AW, Gardiner TA, Archer DB. Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol 1995; 79: 362.
29. Silverstein JL, Steen VD, Medsger TA Jr, Falanga V. Cutaneous hypoxia in patients with systemic sclerosis (scleroderma). Arch Dermatol 1988; 124: 1379.
30. Camilleri JP, Fiessinger JN, Debure C, et al. Fine structural capillary changes and basal lamina thickening in scleroderma (progressive systemic sclerosis) and Raynaud's disease. Pathol Res Pract 1984; 178: 230.
31. Sims DE. Diversity within pericytes. Clin Exp Pharmacol Physiol 2000; 27: 842.
32. Rajkumar VS, Sundberg C, Abraham DJ, Rubin K, Black CM. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum 1999; 42: 930.
33. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295.
34. Sfikakis PP, McCune BK, Tsokos M, Aroni K, Vayiopoulos G, Tsokos GC. Immunohistological demonstration of transforming growth factor-beta isoforms in the skin of patients with systemic sclerosis. Clin Immunol Immunopathol 1993; 69: 199.
35. Gruschwitz M, Müller PU, Sepp N, Hofer E, Fontana A, Wick G. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 1990; 94: 197.
36. Kawakami T, Soma Y, Mizoguchi M, Saito R. Immunohistochemical expression of transforming growth factor beta3 in calcinosis in a patient with systemic sclerosis and CREST syndrome. Br J Dermatol 2000; 143: 1098.